Swiftwater, PA -
On May 25, 2017 Sanofi Pasteur, a global company with US headquarters located in Swiftwater Pennsylvania, had a ribbon cutting ceremony for their new Quality Control Facility. The project includes three new buildings and has added approximately 170,000 SF to the campus. They include a 97,000-SF Quality Control Laboratory Building, a 52,000-SF Global Clinical Immunology Laboratory Building and a 20,000-SF connector between both facilities.
Sanofi Pasteur is the vaccines division of Sanofi, providing more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe and employs more than 3,000 employees in the United States.
The new Quality Control Facility was built to support the increasing volume of tests required by the continuous growth of existing products, while also welcoming all innovative analytical methods needed for their next generation of products such as their investigational Clostridium difficile and dengue vaccines. The facility will provide the testing support required for the new influenza production facility under construction at the east end of the campus. Without the new quality control capacity, the growth in their influenza production would not have been possible.
The decision to locate this facility in Swiftwater results from the site's strong quality and compliance performance. The state-of-the-industry facility combines office and laboratory space, and will support the quality testing for the company's manufactured products. The new facility aligns with best-in-class design for laboratories, continuing to demonstrate Sanofi's commitment to safety, quality and the future of technology.
The Quality Control Facility was a $64 million investment, providing approximately 200 jobs during construction, accommodates workspace for 240 employees, and provides testing capabilities for products manufactured on site as well as testing capabilities for future growth.
The Swiftwater site was founded in 1897 by Dr. Richard Slee as the Pocono Biological Laboratories, which later became part of the National Drug Company, then Connaught Laboratories, followed by Pasteur Merieux Connaught, and Aventis Pasteur. This site now has 120 years of vaccine experience, more than 50 buildings, and is a global center of scientific and industrial expertise. Swiftwater has a dedicated workforce of more than 2,500 people in Industrial Operations, R&D, Commercial Operations, and various Support Functions. Sanofi Pasteur's Swiftwater campus is designed and built to standards that allow Sanofi Pasteur to switch from production of seasonal influenza vaccine to pandemic influenza vaccine.
Since 2000, the Swiftwater site has made a number of investments to support the changing needs of public health including: Construction of a new Formulation, Filling and Lyophilization facility, to provide yellow fever vaccine and the dengue fever vaccine1 began in 2014 with FDA licensure anticipated in 2018. The Quality Control facility to provide testing capabilities for all products manufactured on site and construction for the new Global Clinical Immunology facility featuring bio-safety level laboratory space which broke ground in 2015 and will support the development of the company's new vaccines portfolio..
After doubling its global vaccine production capacity in the past 10 years, Sanofi Pasteur now produces more than 200 million doses of seasonal influenza vaccine for worldwide distribution. Sanofi Pasteur provides approximately 40% of the global influenza vaccine supply and at least 60 million doses for the United States. Sanofi Pasteur is actively exploring several leading influenza vaccine developments, ranging from broadly protective to universal flu vaccines, through both internal and external collaborations. Sanofi Pasteur has played a critical role in responding to the changing needs of public health by developing innovative products such as combination pediatric vaccines, meningococcal meningitis vaccines, and novel influenza vaccines.
For more information on Sanofi Pasteur visit www.sanofipasteur.com
